ZhewuJWangMD

PubMed

• 13 citations
  Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder.
  Caroline M Nievergelt, Adam X Maihofer, Elizabeth G Atkinson, Chia-Yen Chen, Karmel W Choi
  Nature Genetics. 2024-05-01
• FLI1 in PBMCs contributes to elevated inflammation in combat-related posttraumatic stress disorder.
  Pengfei Li, Liu Liu, Shufeng Liu, Zhongyang Lu, Perry V Halushka
  Frontiers in Psychiatry. 2024-01-01
• 2 citations
  Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study.
  Zhewu Wang, Zachary D Zuschlag, Ursula S Myers, Mark Hamner
  Depression and Anxiety. 2022-04-01

Journal Articles

• The relationship between combat-related posttraumatic stress disorder and the 5-HTTLPR/rs25531 polymorphism  
  Wang Z, Baker DG, Harrer J, Hamner M, Price M, Amstadter A, Depress Anxiety, 1/1/2011
• 5-HTTLPR Influence PTSD Treatment Outcome  
  Wang Z, Harrer J, Tuerk P, Acierno R, Timmerman M, Abbott T, Biol Psychiatry, 1/1/2009
• Serotonin Transporter Genotypes: Stress Vulnerability and Treatment Outcome  
  Wang Z, Harrer J, Geracioti T, Biol Psychiatry, 1/1/2008
• Atomoxetine treatment of ADHD in Tourette syndrome: Reduction in motor cortex inhibition correlates with clinical improvement  
  Gilbert DL, Zhang J, Lipps TD, Natarajan N, Brandyberry J, Wang Z, Sallee FR, Wassermann EM, Clinical Neurophysiology, 1/1/2007
• Short interval cortical inhibition: An endophenotype of ADHD is influenced by 5-HTTLPR genotype  
  Wang Z, Natarajan N, Zhang J, Lipps TD, White C, Gilbert DL, Biol Psychiatry, 1/1/2007
• Dopamine transporter genotype influences the physiological response to medication in ADHD  
  Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM, Brain, 1/1/2006
• Dopamine transporter genotypes influence on ADHD medication effects on cortical inhibition  
  Wang Z, Gilbert DL, Sallee FR, Wassermann EM, Zhang J, White C, Biol Psychiatry, 1/1/2006
• Serotonin transporter genotype: A risk factor for stress related psychopathology  
  Wang Z, Harrer J, Baker D, Geracioti T, Biol Psychiatry, 1/1/2004
• Possible association of a cholecystokinin promoter variant to schizophrenia  
  Wang Z, Wassink T, Crowe RR, Andreasen N, Am J Med Genet, 1/1/2002
• Population-based association analyses of the HOPA 12bp polymorphism for schizophrenia and hypothyroidism  
  Philibert RA, Sandhu HK, Hutton AM, Wang Z, Arndt S, Andreasen NC, Crowe R, Wassink TH, Am J Med Genet, 1/1/2001
• Investigation of candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism  
  DeLisi LE, Smith AB, Razi K, Stewart J, Wang Z, Sandhu HK, Philibert RA, Am J Med Genet, 1/1/2000
• An association of NAG levels and a Mutation of the CCK gene in panic disorder patients  
  Garvey MJ, Crowe RR, Wang Z, Psychiatry Res, 1/1/1998
• Possible association of a cholecystokinin promotor polymorphism (CCK 36CT) with panic disorder  
  Wang Z, Valdes J, Noyes R, Zoega T, Crowe RR, Am J Med Genet, 1/1/1998
• A candidate gene study of 8 GABAA receptor subunits in panic disorder  
  Crowe RR, Wang Z, Noyes R, Albrecht BE, Darlinson MG, Bailey ME, Johnson KJ, Zoega T, Am J Psychiat, 1/1/1997
• Missense mutation in cholecystokinin B receptor gene: Lack of association with panic disorder  
  Keto M, Wang Z, Zoega T, Crowe RR, Am J Med Genet, 1/1/1996
• Exclusion of close linkage between the synaptic vesicular monamine transporter locus and schizophrenia spectrum disorders  
  Persico AM, Wang Z, Black DW, Andreasen NC, Uhl GR, Crowe RR, Am J Med Genet, 1/1/1995
• Exclusion of close linkage of dopamine transporter gene with schizophrenia spectrum disorders  
  Persico AM, Wang Z, Black DW, Andreasen NC, Uhl G, Crowe RR, Am J Psychiat, 1/1/1995
• No evidence of a schizophrenia locus in a second pseudoautosomal region  
  Wang Z, Black DW, Andreasen NC, Crowe RR, Arch Gen Psychiat, 1/1/1994
• An SspI polymorphism for the human DOPA decarboxylase (DDC) gene on chromosome 7p  
  Wang Z, Crowe RR, Marsh JL, Hum Mol Genet, 1/1/1993
• A linkage study of chromosome 11q in schizophrenia  
  Wang Z, Black DW, Andreasen NC, Crowe RR, Arch Gen Psychiat, 1/1/1993
• Pseudo-autosomal locus for schizophrenia excluded in 12 pedigrees  
  Wang Z, Black DW, Andreasen NC, Crowe RR, Arch Gen Psychiat, 1/1/1993
• Adrenergic receptor genes in panic disorder: A linkage study  
  Wang Z, Crowe RR, Noyes R, Am J Psychiat, 1/1/1992
• Alcoholism and the D2 receptor gene  
  Cook BL, Wang Z, Crowe RR, Hauser R, Frimer M, Alcoholism Clin Experiment Res, 1/1/1992
• Alpha2 adrenergic receptor gene in depression  
  Wang Z, Crowe RR, Winokur G, J Affective Disorder, 1/1/1992
• Paranoid disorder among postmenstrual women  
  Wang Z, Wu Y, Hu J, J Harbin Med Univ, 1/1/1987
• Join now to see all

Abstracts/Posters

• Serotonin and Dopamine Transporter Genotypes: Impact on Treatment Outcome in PTSD.
  Wang Z, Clapp J, Mendal H, Hamner M, Myrick D, 2012 Pharmacogenetics in Psychiatry Meeting, 1/1/2012
• 5-HTTLPR Influence PTSD Treatment Outcome.
  Wang Z, Harrer J, Tuerk P, Acierno R, Timmerman M, Abbott T, 2009 Annual Meeting of Society of Biological Psychiatry, 1/15/2009
• 5-HTTLPR and PTSD Pharmacotherapy Psychotherapy Outcomes.
  Wang Z, Abbott T, 2009 Annual Meeting of Anxiety Disorders Association of America, 1/14/2009
• Serotonin Transporter Genotypes: Stress Vulnerability and Treatment Outcome.
  Wang Z, Harrer J, Geracioti T, 2008 Annual Meeting of Society of Biological Psychiatry, 1/17/2008
• Short Interval Cortical Inhibition: An Endophenotype of ADHD is influenced by 5-HTTLPR Genotype.
  Wang Z, Natarajan N, Zhang J, Lipps TD, White C, Gilbert DG, 2007 Annual Meeting of Society of Biological Psychiatry, 1/17/2007
• Dopamine Transporter Genotypes Influence on ADHD Medication Effects on Cortical Inhibition.
  Wang Z, Gilbert DG, Sallee FR, Wassermann EM, 2006 Annual Meeting of Society of Biological Psychiatry, 1/20/2006
• Serotonin transporter genotype: A risk factor for stress related psychopathology.
  Wang Z, Harrer J, Baker D, Geracioti T, Annual Meeting of Society of Biological Psychiatry, 1/1/2004
• Possible association of a cholecystokinin promoter variant to schizophrenia.
  Wang Z, Wassink T, Crowe RR, Andreasen N, Society of Biological Psychiatry Jr. Research Trainee Travel Award, 1/1/2000
• Cholecystokinin promotor polymorphism (CCK 36CT) and panic disorder.
  Wang Z, Noyes R, Zoega T, Crowe RR, APA/Lilly Resident Research, 1/1/1997
• Join now to see all

Lectures

• Co-occurrence of Adult ADHD in PTSD: Prevalence, Genetic Risk, and Impact on Clinical Outcomes. 
  New York, NY - 1/10/2014
• Dopamine Transporter Genotypes Influence on ADHD Medication Effects on Cortical Inhibition. 
  1/1/2013
• Role of Serotonin Transporter Gene in PTSD Development and Treatment Outcome. 
  1/1/2010
• How Genetic Factors Influence in PTSD Development and Treatment Outcome. 
  1/8/2008
• Serotonin Transporter Genes and PTSD Risk. 
  1/11/2006
• Monoamine Transporter Genotypes and PTSD Risk. 
  1/1/2006
• Join now to see all

Other

• Review in medical examination for advancement in Medicine: Psychiatry. 
  Ming H, Wang Z, Hu J, Heilongjiang Provincial Press
  Heilongjiang, People's Republic of China - 1/1/1984